Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 1—January 2020
Synopsis

Candidatus Mycoplasma haemohominis in Human, Japan

Norimichi Hattori1Comments to Author , Makoto Kuroda1, Harutaka Katano1, Takahiro Takuma1, Takayoshi Ito1, Nana Arai, Ryo Yanai, Tsuyoshi Sekizuka, Sho Ishii, Yoko Miura, Takahiro Tokunaga, Hiroyuki Watanabe, Norihiro Nomura, Junichi Eguchi, Hideki Hasegawa, Tsuyoshi Nakamaki, Takaji Wakita, and Yoshihito Niki
Author affiliations: Showa University School of Medicine, Tokyo, Japan (N. Hattori, T. Takuma, N. Arai, R. Yanai, S. Ishii, Y. Miura, T. Tokunaga, T. Nakamaki, Y. Niki); National Institute of Infectious Diseases, Tokyo (M. Kuroda, H. Katano, T. Sekizuka, H. Hasegawa, T. Wakita); Showa Uuniversity Koto Toyosu Hospital, Tokyo (T. Ito, H. Watanabe, N. Nomura, J. Eguchi)

Main Article

Figure 7

Copy number of the Candidatus Mycoplasma haemohominis genome in 1-μL serum samples from a 42-year-old man, Japan. Copy number was determined by using a real-time PCR. LVFX, levofloxacin; MINO, minocycline; MLFX, moxifloxacin.

Figure 7. Copy number of the Candidatus Mycoplasma haemohominis genome in 1-μL serum samples from a 42-year-old man, Japan. Copy number was determined by using a real-time PCR. LVFX, levofloxacin; MINO, minocycline; MLFX, moxifloxacin.

Main Article

1These authors contributed equally to this article.

Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external